These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5963798)

  • 1. Treatment of outpatients in the psychiatric practice with nuredal and its combinations.
    Hárdi I; Saághy M
    Ther Hung; 1966; 14(4):159-63. PubMed ID: 5963798
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine oxidase inhibitors, their structural analogues, and neuroprotection.
    Sowa BN; Holt A; Todd KG; Baker GB
    Indian J Exp Biol; 2004 Sep; 42(9):851-7. PubMed ID: 15462176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of IMAO on glycemic equilibrium: potentiation of insulinic hypoglycemia by beta-phenyl-ethyl-hydrazine (Nardil)].
    Patrignani A; Miele V
    G Psichiatr Neuropatol; 1968; 96(1):29-43. PubMed ID: 5712513
    [No Abstract]   [Full Text] [Related]  

  • 4. [Monoamine oxidase inhibitors: various clinical remarks on phenelzine].
    Guyotat J; Favre-Tissot M; Marie-Cardine M
    J Med Lyon; 1966 Jun; 47(101):1009-15. PubMed ID: 4914860
    [No Abstract]   [Full Text] [Related]  

  • 5. MAOIs and drug interactions--a proposal for a clearinghouse.
    Shader RI; Greenblatt DJ
    J Clin Psychopharmacol; 1985 Jun; 5(3):A17. PubMed ID: 3998202
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoamine oxidase inhibitors move up the menu.
    Drug Ther Bull; 1989 Aug; 27(16):63-4. PubMed ID: 2519126
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of monoamine oxidase inhibitors in therapy].
    Hazard J; Aimez P
    Cah Coll Med Hop Paris; 1969 Sep; 10(11):921-8. PubMed ID: 5376763
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of combined use of monoamine oxidase inhibitors and psychotherapy in the treatment of chronic alcoholism].
    Bobrov AE; Shurygin AN; Krasil'nikov SB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(2):79-83. PubMed ID: 1647635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic problem in pre, post and long-term drug therapy of mental disorders in outpatient practice].
    Kühne GE
    Z Arztl Fortbild (Jena); 1966 Jul; 60(13):790-5. PubMed ID: 5994703
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical pharmacology of MAO inhibitors: safety and future.
    Yamada M; Yasuhara H
    Neurotoxicology; 2004 Jan; 25(1-2):215-21. PubMed ID: 14697896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drugs in psychiatry.
    Pollitt J
    Br J Hosp Med; 1983 Apr; 29(4):340-7. PubMed ID: 6135472
    [No Abstract]   [Full Text] [Related]  

  • 12. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association.
    American Psychiatric Association Practice Guidelines
    Am J Psychiatry; 2001 Oct; 158(10 Suppl):1-52. PubMed ID: 11665545
    [No Abstract]   [Full Text] [Related]  

  • 13. [A few cases illustrating the hazards of MAOI antidepressive agents].
    Boudin G; Lauras A
    Therapie; 1965; 20(5):1241-8. PubMed ID: 5850103
    [No Abstract]   [Full Text] [Related]  

  • 14. [Why knowing about the mechanisms of psychoactive drugs?].
    Zieher LM
    Vertex; 2003; 14(51):23-4. PubMed ID: 12710413
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness and tolerability of selegiline in the treatment of pathological cerebral involutions].
    Bettini R; Gorini M
    Clin Ter; 2002; 153(6):377-80. PubMed ID: 12645393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of reversible inhibitors of monamine oxidase-A in major depression and other psychiatric disorders. Proceedings of a symposium. Athens, Greece, 13-19 October 1989.
    Acta Psychiatr Scand Suppl; 1990; 360():1-34. PubMed ID: 2248057
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monoamine oxidase inhibitors in treatment of bulbar ulcer: 10 treated cases].
    Marquier A
    Arch Fr Mal App Dig; 1968 Jun; 57(4):511-2. PubMed ID: 5741156
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined and selective monoamine oxidase inhibition in the treatment of depression in Parkinson's disease.
    Jansen Steur EN; Ballering LA
    Adv Neurol; 1999; 80():505-8. PubMed ID: 10410764
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indications and results of the treatment of mental depression by octamoxine (ximaol)].
    Gayral L; Stern H; Puyuelo R
    Therapie; 1966; 21(5):1183-90. PubMed ID: 5976767
    [No Abstract]   [Full Text] [Related]  

  • 20. Rediscovering monoamine oxidase inhibitors.
    Bass C; Kerwin R
    BMJ; 1989 Feb; 298(6670):345-6. PubMed ID: 2493930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.